In silico study of thymohydroquinone interaction with blood–brain barrier disrupting proteins

AIM: To evaluate the inhibitory interaction of thymohydroquinone against blood–brain barrier (BBB)-associated neuropsychiatric and neurodegenerative disorders. MATERIALS & METHODS: An elaborated in silico study was designed to evaluate the interaction of thymohydroquinone with BBB-disrupting pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Fahad Hassan, Salman, Saad, Idrees, Jawaria, Idrees, Fariha, Akbar, Muhammad Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720366/
https://www.ncbi.nlm.nih.gov/pubmed/33312701
http://dx.doi.org/10.2144/fsoa-2020-0115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720366/
https://www.ncbi.nlm.nih.gov/pubmed/33312701
http://dx.doi.org/10.2144/fsoa-2020-0115

Ejemplares similares